Tag: GLP-1 import ban
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
The FDA uses Import Alerts to block drugs from non-compliant manufacturers, automatically detaining shipments without inspection. Learn how the Green List works, why Indian and Chinese suppliers are being targeted, and what manufacturers must do to stay in the U.S. market.
view morerecent posts
Statin-related liver enzyme elevations are common but rarely dangerous. Learn when to worry, when to ignore, and why stopping your statin over a lab result could put your heart at risk.
Published ON: 2 FebGeneric drugs cost far less than brand-name drugs not because ingredients are cheaper, but because labor costs are structured differently. Learn how scale, regulation, and global production shape the real cost of your prescriptions.
Published ON: 9 FebTeam-based care transforms how generic drugs are prescribed by bringing together doctors, pharmacists, and nurses to improve safety, adherence, and cost savings - especially for patients with multiple chronic conditions.
Published ON: 18 FebHyponatremia and hypernatremia are common, dangerous complications in kidney disease. Learn how sodium imbalances happen, why standard treatments fail, and what actually works to protect your health.
Published ON: 8 FebPolycystic kidney disease is a genetic disorder causing cysts to grow in the kidneys, leading to kidney failure. Learn how ADPKD and ARPKD work, how to manage symptoms, and what new treatments are on the horizon.
Published ON: 7 Feb